Jeffrey Ryan Stewart
CIK: 0001761675
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AbbVie Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Feb 27, 2026ABBV
AbbVie Inc.
Tax Payment(F)Direct23.8K shares at avg. $232.08$5.5M - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct9.4K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct9.3K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct26.1K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct9K shares- - Mar 31, 2025ABBV
AbbVie Inc.
Exercise(M)Direct25.7K shares at avg. $79.02$2.0M - Mar 31, 2025ABBV
AbbVie Inc.
Sale(S)Direct25.7K shares at avg. $209.49$5.4M - Mar 31, 2025ABBV
AbbVie Inc.
Sale(S)Direct33.1K shares at avg. $210.54$7.0M - Feb 28, 2025ABBV
AbbVie Inc.
Tax Payment(F)Direct20.2K shares at avg. $205.02$4.1M - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct9.4K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct9.3K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct7.8K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct19.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 27, 2026 | ABBV AbbVie Inc. | Tax Payment(F) | 23,812 | $232.08 | $5,526,289 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 9,432 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 9,266 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 26,063 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 8,988 | - | $0 | Direct |
| Mar 31, 2025 | ABBV AbbVie Inc. | Exercise(M) | 25,700 | $79.02 | $2,030,814 | Direct |
| Mar 31, 2025 | ABBV AbbVie Inc. | Sale(S) | 25,700 | $209.49 | $5,383,893 | Direct |
| Mar 31, 2025 | ABBV AbbVie Inc. | Sale(S) | 33,132 | $210.54 | $6,975,611 | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Tax Payment(F) | 20,226 | $205.02 | $4,146,735 | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 9,432 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 9,268 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 7,840 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 19,111 | - | - | Direct |
1-13 of 13 transactions
About Stewart Jeffrey Ryan
Stewart Jeffrey Ryan (SEC CIK 0001761675) files insider reports with the SEC as EVP, CHIEF COMMERCIAL OFFICER of AbbVie Inc. (ABBV).
Signal8 holds 5 ownership filings by Stewart Jeffrey Ryan, all Form 4s, filed between Feb 18, 2025 and Mar 3, 2026. Those filings report 13 transactions, from Feb 13, 2025 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Stewart Jeffrey Ryan's filings is in NORTH CHICAGO, IL.
Recent filings by Stewart Jeffrey Ryan
- Feb 27, 2026: Tax withholding of ABBV shares (Form 4, code F).
- Feb 18, 2026: Grants or awards of ABBV shares (4 lines, Form 4, code A).
- Mar 31, 2025: Option exercise of ABBV shares (Form 4, code M).
- Mar 31, 2025: Open-market sales of ABBV shares (2 lines, Form 4, code S).
- Feb 28, 2025: Tax withholding of ABBV shares (Form 4, code F).
Other insiders filing for AbbVie Inc. (ABBV)
- Carethers John, Director
- Quaggin Susan E, Director
- RAPP EDWARD J, Director
- Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER
- FALK THOMAS J, Director
- WADDELL FREDERICK H, Director